Matthew Plunkett

EVP, Corporate Development, CTI BioPharma.

Companies

Imago BioSciences, Inc.Chief financial officer Jul 15, 2021 to Jul 15, 2021¹
Nkarta Therapeutics (United States)Chief financial officer Jul 9, 2020 to Jul 13, 2020²
CTI BioPharmaBoard member Mar 6, 2017 to Mar 6, 2017³
CTI BioPharmaEVP, Corporate Development Sep 7, 2012 to Mar 6, 2017⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImago BioSciences, Inc., Chief financial officer
2
SEC EDGARNkarta Therapeutics (United States), Chief financial officer
3
SEC EDGARCTI BioPharma, Board member
4
SEC EDGARCTI BioPharma, EVP, Corporate Development